What is the typical dosing for Guaifenesin (expectorant) with Codeine (opioid cough suppressant) for relief of cough and congestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guaifenesin with Codeine Dosing for Cough and Congestion Relief

The standard dosing for guaifenesin with codeine is 10 mg codeine phosphate and 100 mg guaifenesin per 5 mL (teaspoonful), with typical adult dosing of 10 mL (20 mg codeine/200 mg guaifenesin) every 4-6 hours as needed for cough and congestion relief. 1

Dosing Guidelines

Codeine Component

  • Codeine is an opioid cough suppressant that acts centrally to suppress the cough reflex 2
  • Standard adult dosing range: 30-60 mg every 4-6 hours (maximum 240 mg in 24 hours) 2
  • For combination products with guaifenesin, the codeine component is typically dosed at 10-20 mg per dose 1
  • Codeine is effective for short-term symptomatic relief of coughing in chronic bronchitis 2

Guaifenesin Component

  • Guaifenesin is an expectorant that helps loosen phlegm and bronchial secretions 2
  • Standard adult dosing: 100-400 mg every 4 hours 3
  • Extended-release formulations are available allowing for 12-hour dosing 4
  • Guaifenesin has been shown to decrease sputum thickness and viscosity in patients with productive cough 5

Clinical Application Algorithm

  1. Initial Assessment

    • Determine if the cough is productive (wet) or non-productive (dry) 2
    • Guaifenesin with codeine is most appropriate for productive cough with chest congestion 3
  2. Dosing Schedule

    • Standard immediate-release formulation:
      • 5-10 mL (10-20 mg codeine/100-200 mg guaifenesin) every 4-6 hours as needed 1
      • Maximum daily dose: 40 mL (80 mg codeine/800 mg guaifenesin) 2
  3. Duration of Treatment

    • Short-term use only (typically 5-7 days) 2
    • Reassess if symptoms persist beyond one week 2

Special Considerations

  • Efficacy Evidence: Studies comparing guaifenesin alone versus guaifenesin with codeine show similar effectiveness in relieving cough symptoms, but the combination may provide better symptomatic relief for severe cough 6

  • Safety Considerations:

    • Codeine may cause drowsiness, constipation, and respiratory depression at higher doses 2
    • Guaifenesin is generally well-tolerated with minimal side effects at recommended doses 3
    • Avoid in patients with chronic bronchitis and bronchiectasis as cough suppressants can cause sputum retention 2
  • Alternative Options:

    • For milder cough: Consider guaifenesin alone or dextromethorphan 2
    • For severe cough unresponsive to codeine: Consider morphine sulfate oral solution (2.5-5 mg every 4 hours) 2

Common Pitfalls and Caveats

  • Avoid prolonged use: Codeine is habit-forming and should be used for the shortest duration possible 2
  • Respiratory depression risk: Use with caution in elderly patients or those with respiratory compromise 2
  • Overdose potential: Guaifenesin overdose has been associated with CNS depression in rare cases 7
  • Drug interactions: Use caution when combining with other CNS depressants 2
  • Therapeutic expectations: Set realistic expectations - these medications provide symptomatic relief but do not shorten the duration of illness 2

Remember that while guaifenesin with codeine can provide effective symptomatic relief for cough and congestion, it should be used judiciously and for short durations to minimize the risk of adverse effects and dependence 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.